Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
In the latest session, Oscar Health Inc (NYSE: OSCR) closed at $14.38 down -7.41% from its previous closing price of $15.53. In other words, the price has decreased by -$7.41 from its previous closing price. On the day, 56.22 million shares were traded. OSCR stock price reached its highest trading level at $15.08 during the session, while it also had its lowest trading level at $14.125.
Ratios:
For a deeper understanding of Oscar Health Inc’s stock, let’s take a closer look at its various ratios. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.22.
On July 02, 2025, Barclays started tracking the stock assigning a Underweight rating and target price of $17.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jun 20 ’25 when RANMALI BOPITIYA bought 30,000 shares for $18.77 per share.
ALESSANDREA QUANE bought 148,280 shares of OSCR for $2,598,488 on May 16 ’25. On May 12 ’25, another insider, Robinson Elbert O. Jr., who serves as the Director of the company, sold 25,000 shares for $16.43 each. As a result, the insider received 410,750 and left with 64,512 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OSCR now has a Market Capitalization of 3662255104 and an Enterprise Value of 2827629312. As of this moment, Oscar’s Price-to-Earnings (P/E) ratio for their current fiscal year is 51.62, and their Forward P/E ratio for the next fiscal year is 22.41. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.36. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.36 while its Price-to-Book (P/B) ratio in mrq is 2.73. Its current Enterprise Value per Revenue stands at 0.28 whereas that against EBITDA is 14.146.
Stock Price History:
The Beta on a monthly basis for OSCR is 1.89, which has changed by -0.10124999 over the last 52 weeks, in comparison to a change of 0.1116153 over the same period for the S&P500. Over the past 52 weeks, OSCR has reached a high of $23.79, while it has fallen to a 52-week low of $11.20. The 50-Day Moving Average of the stock is -10.74%, while the 200-Day Moving Average is calculated to be -7.35%.
Shares Statistics:
For the past three months, OSCR has traded an average of 15.45M shares per day and 36029090 over the past ten days. A total of 217.98M shares are outstanding, with a floating share count of 180.17M. Insiders hold about 29.26% of the company’s shares, while institutions hold 61.97% stake in the company. Shares short for OSCR as of 1749772800 were 29748645 with a Short Ratio of 1.85, compared to 1747267200 on 19074655. Therefore, it implies a Short% of Shares Outstanding of 29748645 and a Short% of Float of 15.120000000000001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
Its stock is currently analyzed by 4.0 different market analysts. The consensus estimate for the next quarter is -$0.14, with high estimates of -$0.02 and low estimates of -$0.24.
Analysts are recommending an EPS of between $0.84 and $0.59 for the fiscal current year, implying an average EPS of $0.68. EPS for the following year is $1.19, with 4.0 analysts recommending between $1.88 and $0.85.
Revenue Estimates
A total of 7 analysts believe the company’s revenue will be $2.88B this quarter.It ranges from a high estimate of $3B to a low estimate of $2.72B. As of the current estimate, Oscar Health Inc’s year-ago sales were $2.22BFor the next quarter, 7 analysts are estimating revenue of $2.76B. There is a high estimate of $2.83B for the next quarter, whereas the lowest estimate is $2.69B.
A total of 8 analysts have provided revenue estimates for OSCR’s current fiscal year. The highest revenue estimate was $11.29B, while the lowest revenue estimate was $11.05B, resulting in an average revenue estimate of $11.24B. In the same quarter a year ago, actual revenue was $9.18BBased on 8 analysts’ estimates, the company’s revenue will be $11.09B in the next fiscal year. The high estimate is $12.64B and the low estimate is $9.03B.
